Global /India /Healthcare /Drug Manufacturers - General /APLLTD

Alembic Pharmaceuticals Ltd.

APLLTD

• NSE: APLLTD • Delayed

755.00INR -0.8%

7.89 USD

As of 5 June 2026, Alembic Pharmaceuticals Ltd. has a market cap of $1.56B USD, ranking #8258 globally and #443 in India. It ranks #695 in the Healthcare sector, and #265 in the Drug Manufacturers - General industry.

Global Rank

8258

Country Rank

443

Sector Rank

695

Industry Rank

265

Key Stats

Market Cap

$1.56BUSD

149.6B INR

Enterprise Value

$1.7BUSD

163.03B INR

Revenue (TTM)

$758.93MUSD

72.67B INR

EBITDA (TTM)

$117.74MUSD

11.27B INR

Net Income (TTM)

$65.69MUSD

6.29B INR

EBITDA Margin

16%

Profit Margin

8.7%

PE Ratio

23.7

Forward PE

18.8

PS Ratio

2.1

PB Ratio

2.8

EV/EBITDA

14.2

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Chirayu Amin open_in_new

Employees

16,571

Founded

1907

Website

alembicpharmaceuticals.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	-0.4%	13%	-0.3%	-16%	-10%	-13%	37%	-23%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	APLLTD Alembic Pharmaceuticals Ltd ISIN: INE901L01018 Shares Out.: Shares Outstanding: 196.563M¹ Shares Float: 58.334M² TV: TradingView: NSE: APLLTD SA: Stock Analysis: NSE: APLLTD YF: Yahoo Finance: APLLTD.NS GF: Google Finance: NSE: APLLTD BA: Barron's: APLLTD MS: Morningstar: XNSE: APLLTD	755.00 INR	TV: TradingView: NSE: APLLTD SA: Stock Analysis: NSE: APLLTD YF: Yahoo Finance: APLLTD.NS GF: Google Finance: NSE: APLLTD BA: Barron's: APLLTD MS: Morningstar: XNSE: APLLTD
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	533573 (APLLTD) Alembic Pharmaceuticals Ltd ISIN: INE901L01018 TV: TradingView: BSE: APLLTD SA: Stock Analysis: BOM: 533573 YF: Yahoo Finance: 533573.BO GF: Google Finance: BOM: 533573 BA: Barron's: 533573 MS: Morningstar: XBOM: 533573	761.45 INR	TV: TradingView: BSE: APLLTD SA: Stock Analysis: BOM: 533573 YF: Yahoo Finance: 533573.BO GF: Google Finance: BOM: 533573 BA: Barron's: 533573 MS: Morningstar: XBOM: 533573

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.57B 4.27T INR 3K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.12B 1.73T INR 1K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$14.95B 1.43T INR 857%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.57B 1.11T INR 640%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.73B 931.67B INR 523%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.57B 916.53B INR 513%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 49K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 35K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 23K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 21K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 18K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 18K%	20.5	Switzerland

chevron_leftBack